IN2013MU03468A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03468A
IN2013MU03468A IN3468MU2013A IN2013MU03468A IN 2013MU03468 A IN2013MU03468 A IN 2013MU03468A IN 3468MU2013 A IN3468MU2013 A IN 3468MU2013A IN 2013MU03468 A IN2013MU03468 A IN 2013MU03468A
Authority
IN
India
Prior art keywords
linagliptin
preparation
amorphous form
milling
abstract
Prior art date
Application number
Other languages
English (en)
Inventor
Shri Prakash Dhar Dwivedi
Kumar Kamlesh Singh
Jitendra Maganbhai Gajera
Ganpat Dan Shimbhu Charan
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN3468MU2013 priority Critical patent/IN2013MU03468A/en
Publication of IN2013MU03468A publication Critical patent/IN2013MU03468A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
IN3468MU2013 2013-10-31 2013-10-31 IN2013MU03468A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3468MU2013 IN2013MU03468A (fr) 2013-10-31 2013-10-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3468MU2013 IN2013MU03468A (fr) 2013-10-31 2013-10-31

Publications (1)

Publication Number Publication Date
IN2013MU03468A true IN2013MU03468A (fr) 2015-07-17

Family

ID=54397514

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3468MU2013 IN2013MU03468A (fr) 2013-10-31 2013-10-31

Country Status (1)

Country Link
IN (1) IN2013MU03468A (fr)

Similar Documents

Publication Publication Date Title
EP3172214A4 (fr) 2-amino-pyrido [2,3-d]pyrimidin -7 (8h)-one utilisés en tant qu'inhibiteurs de cdk et utilisations de ceux-ci
TW201613906A (en) Amorphous body of tetracyclic compound
AU357122S (en) Headgear for patient interface
EP3008168A4 (fr) Cellules dérivées de cellules souches et compositions et procédés pour générer ces cellules
EP3130770A4 (fr) Système intégré optimisé pour production d'électricité hybride solaire-biomasse
AU2012209332A8 (en) Methods and compositions for preparing noribogaine from voacangine
EP3073870A4 (fr) Ensemble support de siège de hanche
MX2015002487A (es) Proceso para la preparacion de teneligliptina.
EP3074426A4 (fr) Procédé de broyage
TW201144301A (en) Processes for preparing linezolid
EP3025527A4 (fr) Génération de géobarrières
IN2013MU00646A (fr)
EP3063271A4 (fr) Méthodes et compositions pour induire une génération des lymphocytes t régulateurs
MX2015013021A (es) 5-bromo-indirrubinas.
EP3223817A4 (fr) Vemurafenib sensiblement pur et ses sels
IN2013MU01111A (fr)
EP3082801A4 (fr) Procédé économique et avancé pour la préparation de vildagliptine pure
IN2013CH04314A (fr)
IN2013MU03468A (fr)
MX2016002186A (es) Proceso para preparar dronedarona y sales de la misma.
IN2014CH01391A (fr)
IN2012CH02984A (fr)
IN2013MU01226A (fr)
AU352343S (en) Fitting for furniture
UA90039U (en) Ethyl ester of 6-thioxo-3-(4-fluorophenyl)-7-cyano-1,3,4,6-2h-pyrido[1,2-a][1,3,5]triazine-9-carboxylic acid